Literature DB >> 17636745

Psychological and educational interventions for atopic eczema in children.

S J Ersser1, S Latter, A Sibley, P A Satherley, S Welbourne.   

Abstract

BACKGROUND: Psychological and educational interventions have been used as an adjunct to conventional therapy for children with atopic eczema to enhance the effectiveness of topical therapy. There have been no relevant systematic reviews applicable to children.
OBJECTIVES: To assess the effectiveness of psychological and educational interventions in changing outcomes for children with atopic eczema. SEARCH STRATEGY: We searched the Cochrane Skin Group Specialised Register (to September 2004), the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 2, 2005), MEDLINE (from 1966-2005), EMBASE (from 1980 to week 3, 2005 ), PsycINFO (from 1872 to week 1, 2005). On-line: National Research Register, Meta-register of Controlled Trials, ZETOC alerts, SIGLE (August 2005). SELECTION CRITERIA: RCTs of psychological or educational interventions, or both, used to manage children with atopic eczema. DATA COLLECTION AND ANALYSIS: Two authors independently applied eligibility criteria, assessed trial quality and extracted data. A lack of comparable data prevented data synthesis. MAIN
RESULTS: Five RCTs met the inclusion criteria. Some included studies required clearer reporting of trial procedures. Rigorous established outcome measures were not always used. Interventions described in all 5 RCTs were adjuncts to conventional therapy. Four focused on intervention directed towards the parents; data synthesis was not possible. Psychological interventions remain virtually unevaluated by studies of robust design; the only included study examined the effect of relaxation techniques (hypnotherapy and biofeedback) on severity. Three educational studies identified significant improvements in disease severity between intervention groups. A recent German trial evaluated long term outcomes and found significant improvements in both disease severity (3 months to 7 years, p=0.0002, 8 to 12 years, p=0.003, 13 to 18 years, p=0.0001) and parental quality of life (3 months to 7 years, p=0.0001, 8 to 12 years p=0.002), for children with atopic eczema. One study found video-based education more effective in improving severity than direct education and the control (discussion) (p<0.001). The single psychological study found relaxation techniques improved clinical severity as compared to the control at 20 weeks (t=2.13) but this was of borderline significance (p=0.042). AUTHORS'
CONCLUSIONS: A lack of rigorously designed trials (excluding one recent German study) provides only limited evidence of the effectiveness of educational and psychological interventions in helping to manage the condition of children with atopic eczema. Evidence from included studies and also adult studies indicates that different service delivery models (multi-professional eczema school and nurse-led clinics) require further and comparative evaluation to examine their cost-effectiveness and suitability for different health systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636745     DOI: 10.1002/14651858.CD004054.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  16 in total

1.  Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

Authors:  Robert Sidbury; Wynnis L Tom; James N Bergman; Kevin D Cooper; Robert A Silverman; Timothy G Berger; Sarah L Chamlin; David E Cohen; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Lawrence F Eichenfield
Journal:  J Am Acad Dermatol       Date:  2014-09-26       Impact factor: 11.527

Review 2.  Quality-of-life outcomes and measurement in childhood atopic dermatitis.

Authors:  Sarah L Chamlin; Mary-Margaret Chren
Journal:  Immunol Allergy Clin North Am       Date:  2010-07-01       Impact factor: 3.479

3.  Psychological stress with long-standing allergic dermatitis causes psychodermatological conditions in mice.

Authors:  Hideki Kitagaki; Hidetaka Hiyama; Toshiki Kitazawa; Tetsuo Shiohara
Journal:  J Invest Dermatol       Date:  2014-01-21       Impact factor: 8.551

Review 4.  Non-pharmacologic therapies for atopic dermatitis.

Authors:  Peter A Lio
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 5.  Psychological interventions for parents of children and adolescents with chronic illness.

Authors:  Christopher Eccleston; Tonya M Palermo; Emma Fisher; Emily Law
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

6.  Experiences of carers managing childhood eczema and their views on its treatment: a qualitative study.

Authors:  Miriam Santer; Hana Burgess; Lucy Yardley; Steven Ersser; Sue Lewis-Jones; Ingrid Muller; Catherine Hugh; Paul Little
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

Review 7.  Nerve-derived transmitters including peptides influence cutaneous immunology.

Authors:  Elizabeth N Madva; Richard D Granstein
Journal:  Brain Behav Immun       Date:  2013-03-18       Impact factor: 7.217

Review 8.  Psychological and educational interventions for atopic eczema in children.

Authors:  Steven J Ersser; Fiona Cowdell; Sue Latter; Eric Gardiner; Carsten Flohr; Andrew Robert Thompson; Karina Jackson; Helen Farasat; Fiona Ware; Alison Drury
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

Review 9.  Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Authors:  Rebecca Ryan; Nancy Santesso; Dianne Lowe; Sophie Hill; Jeremy Grimshaw; Megan Prictor; Caroline Kaufman; Genevieve Cowie; Michael Taylor
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

10.  What Should General Practice Trainees Learn about Atopic Eczema?

Authors:  Deepani Munidasa; Antonia Lloyd-Lavery; Susan Burge; Tess McPherson
Journal:  J Clin Med       Date:  2015-02-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.